期刊文献+

腹腔注射内毒素制备脓毒症心肌抑制大鼠模型的验证 被引量:1

Validation of a septic myocardial inhibition model by intraperitoneal injection of endotoxin in rats
原文传递
导出
摘要 目的通过心脏超声方法验证脓毒症心肌抑制大鼠模型的建立。方法按随机数字表法将成年雄性SD大鼠分为对照组和模型组,每组10只。以腹腔注射内毒素10 mg/kg制备脓毒症心肌抑制动物模型;对照组则给予相应体积生理盐水。制模后8 h进行心脏超声检测,分别测量左室舒张期末内径(LVDd)、左室舒张期末容积(LVEDV)、左室收缩期末内径(LVDs)、左室收缩期末容积(LVESV)、左室射血分数(LVEF)、右室舒张期末内径(RVDd)、右室收缩期末内径(RVDs)、心率(HR)、肺动脉正向流速、主动脉流速。随后处死大鼠,获取血清和心肌组织,采用酶联免疫吸附试验(ELISA)测定血清肿瘤坏死因子-α(TNF-α)、核转录因子-?κB(NF-κB)、白细胞介素-1(IL-1)、心肌肌钙蛋白I(cTnI)、B型脑钠肽(BNP)水平;采用实时荧光定量聚合酶链反应(real-time PCR)检测心肌组织TNF-α、IL-1、NF-κB mRNA表达;采用苏木素-伊红(HE)染色,于光镜下观察心肌组织病理学改变。结果与对照组比较,模型组大鼠心肌抑制明显,表现为心脏整体外形扩大,HR明显增快(次/min:449.0±21.1比356.7±23.3,P<0.01),左心和右心功能均有影响,以左心功能受损为主,LVDd、LVDs、LVEDV、LVESV均扩大〔LVDd(mm):10.03±0.95比7.04±0.71,LVDs(mm):5.95±0.71比3.07±0.05,LVEDV(mL):2.11±0.53比0.81±0.21,LVESV(mL):0.51±0.16比0.07±0.01,均P<0.05〕,LVEF明显下降(0.760±0.046比0.901±0.025,P<0.01),RVDd明显增大(mm:4.48±0.58比3.22±0.20,P<0.05),肺动脉正向流速明显下降(cm/s:64.2±9.3比89.0±0.8,P<0.05)。与对照组相比,模型组血清NF-κB、TNF-α、IL-1、BNP、cTnI水平均明显升高〔NF-κB(ng/L):103.84±6.55比57.29±41.34,TNF-α(ng/L):1?198.32±164.07比835.45±24.01,IL-1(ng/L):1?089.90±221.96比746.19±165.83,BNP(ng/L):1?097.36±293.84比454.71±197.79,cTnI(ng/L):6?938.59±1?400.21比3?731.90±1?349.31,均P<0.01〕,心肌组织TNF-α、NF-κB、IL-1的mRNA表达也明显升高(2-ΔΔCT:1.50±0.42比0.71±0.40,1.10±0.17比0.63±0.06,1.77±0.67比0.10±0.03,均P<0.05)。光镜下观察,对照组心肌组织结构正常,心肌纤维排列整齐,细胞间结构清晰;模型组心肌组织间结构较疏松、模糊,细胞肿胀,具有明显的病理学改变。结论经心脏超声、炎性因子表达、心肌标志物测定、病理学观察等评估心功能,验证腹腔注射10 mg/kg内毒素可成功制备脓毒症心肌抑制大鼠模型。 Objective To establish septic myocardial inhibition rat model by echocardiography.Methods Twenty adult male Sprague-Dawley(SD)rats were divided into control group and model group according to the random number table method,with 10 rats in each group.The rat model of septic myocardial inhibition was reproduced by intraperitoneal injection of 10 mg/kg lipopolysaccharide,while the control group was given the same volume of saline.The left ventricular end-diastolic diameter(LVDd),left ventricular end-diastolic volume(LVEDV),left ventricular end-systolic diameter(LVDs),left ventricular end-systolic volume(LVESV),left ventricular ejection fraction(LVEF),right ventricular end-diastolic diameter(RVDd),right ventricular end-systolic diameter(RVDs),heart rate(HR),positive pulmonary artery flow rate and aortic flow rate were measured at 8 hours after model establishment by echocardiography.Then the rats were sacrificed to harvest serum and myocardial tissue.The levels of serum tumor necrosis factor-α(TNF-α),nuclear factor-κB(NF-κB),interleukin-1(IL-1),cardiac troponin I(cTnI)and B-type brain natriuretic peptide(BNP)were measured by enzyme linked immunosorbent assay(ELISA).The mRNA expressions of TNF-α,IL-1 and NF-κB in myocardium were detected by real-time polymerase chain reaction(real-time PCR).The pathological changes of myocardium were observed by hematoxylin-eosin(HE)staining under light microscope.Results Compared with control group,myocardial inhibition was obviously observed in model group,manifesting as enlargement of overall shape of heart,and prominent increase of HR(bpm:449.0±21.1 vs.356.7±23.3,P<0.01);left ventricular and right ventricular functions were affected,LVDd,LVDs,LVEDV,LVESV were enlarged[LVDd(mm):10.03±0.95 vs.7.04±0.71,LVDs(mm):5.95±0.71 vs.3.07±0.05,LVEDV(mL):2.11±0.53 vs.0.81±0.21,LVESV(mL):0.51±0.16 vs.0.07±0.01,all P<0.05],LVEF was significantly decreased(0.760±0.046 vs.0.901±0.025,P<0.01),RVDd was significantly increased(mm:4.48±0.58 vs.3.22±0.20,P<0.05),and positive pulmonary artery velocity was significantly decreased(cm/s:64.2±9.3 vs.89.0±0.8,P<0.05).Compared with control group,the levels of serum NF-κB,TNF-α,IL-1,BNP and cTnI in model group were significantly increased[NF-κB(ng/L):103.84±6.55 vs.57.29±41.34,TNF-α(ng/L):1 198.32±164.07 vs.835.45±24.01,IL-1(ng/L):1 089.90±221.96 vs.746.19±165.83,BNP(ng/L):1 097.36±293.84 vs.454.71±197.79,cTnI(ng/L):6 938.59±1 400.21 vs.3 731.90±1 349.31,all P<0.01],the mRNA expressions of TNF-α,NF-κB and IL-1 in myocardial tissue were significantly increased(2-ΔΔCT:1.50±0.42 vs.0.71±0.40,1.10±0.17 vs.0.63±0.06,1.77±0.67 vs.0.10±0.03,all P<0.05).It was shown by HE staining that the structure of myocardial tissue in control group was distinct,the arrangement of myocardial fibers was neat,and transverse was clear;the structure of myocardial tissue in model group was loose,blurred,and the cells were swollen,with obvious pathological changes.Conclusions Cardiac function was assessed by echocardiography,expression of inflammatory factors,myocardial markers and pathological changes.It was verified that intraperitoneal injection of 10 mg/kg endotoxin could successfully prepare a rat model of septic myocardial inhibition.
作者 赵磊 陈炜 刘勇 甄洁 盛博 臧学峰 陆非平 Zhao Lei;Chen Wei;Liu Yong;Zhen Jie;Sheng Bo;Zang Xuefeng;Lu Feiping(Department of Intensive Care Unit,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China;Department of Ultrasound,Beijing Shijitan Hospital,Capital Medical University,Beijing 100038,China)
出处 《中华危重病急救医学》 CAS CSCD 北大核心 2019年第8期994-997,共4页 Chinese Critical Care Medicine
基金 北京市自然科学基金(7153169) 中国铁路总公司科技研究开发计划(J2014C011-H).
关键词 脓毒症 心肌抑制 大鼠模型 心脏超声 Sepsis Myocardial inhibition Rat model Echocardiography
  • 相关文献

参考文献7

二级参考文献162

  • 1张俊松,王苓,邓节喜,李昌,饶日春,张蓉,郭寿贵.扩张型心肌病左室容积变化对左室射血分数的影响[J].心血管康复医学杂志,1999,8(2):21-23. 被引量:3
  • 2Popovic N ,Mijuskovib O,Neskovi V ,et al. Myocardial dysfunction in septic shock-a case report. Med Pregl , 2008 , 61 : 187-190.
  • 3Gentile G,Meles E,Carbone C,et al. Unusual case of myocardial injury induced by Escherichia coli sepsis. Monaldi Arch Chest Dis, 2010,74:40-43.
  • 4Niebauer 1. Yolk HO, Kemp M, et al.'Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet, 1999,353: 1838-1842,.
  • 5Charalambous BM, Stephens RC, Feavers 1M, et al. Role of bacterial endotoxin in chronic heart failure: the gut of the matter. Shock, 2007,28: 15-23.
  • 6Jessurun GA, Zijlstra F, Siebelink ru Acute ST -segment elevation also possible in non-coronary disorders. Ned Tijdschr Geneeskd, 2006,150:937-942.
  • 7Bouhemad B, Nicolas-Hobin A, Arbelot C, et al. Acute left ventricular dilatation and shock-induced myocardial dysfunction. Crit Care Med, 2009,37 :441-447.
  • 8Muriovo K, Malaska 1. Otevrel F, et a1. Myocardial dysfunction in sepsis-definition and pathogenetic mechanisms. V nitr Lek , 2010,56:220-225.
  • 9Malaska J .Slezok M, Muriovc K, et al, Myocardial dysfunction in sepsis-diagnostics and therapy. V nitr Lek , 2010,56: 226-232.
  • 10Lorigados CB, Soriano FG, Szabo e. Pathomechanisms of myocardial dysfunction in sepsis. Endocr Metab Immune Disord Drug Targets, 2010, 10:274-284.

共引文献147

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部